Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’

Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years

(2017) Joakim Hertze et al.   JOURNAL OF ALZHEIMERS DISEASE

Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study

(2016) Jorge Jovicich et al.   NEUROIMAGE

Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly

(2015) Moira Marizzoni et al.   HUMAN BRAIN MAPPING

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

(2015) Willemijn J. Jansen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

(2015) Sebastian Palmqvist et al.   NEUROLOGY

Auditory Delta Event-Related Oscillatory Responses are Decreased in Alzheimer’s Disease

(2014) G. G. Yener et al.   BEHAVIOURAL NEUROLOGY

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects

(2014) Jorge Jovicich et al.   NEUROIMAGE

The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)

(2014) Shannon Risacher   Frontiers in Aging Neuroscience

Cross-Sectional and Longitudinal Relationships Between Cerebrospinal Fluid Biomarkers and Cognitive Function in People Without Cognitive Impairment From Across the Adult Life Span

(2014) Ge Li et al.   JAMA Neurology

Impaired Visual Recognition Memory Predicts Alzheimer's Disease in Amnestic Mild Cognitive Impairment

(2013) Mira Didic et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Hippocampal and cortical atrophy in amyloid-negative mild cognitive impairments: comparison with amyloid-positive mild cognitive impairment

(2013) Byoung Seok Ye et al.   NEUROBIOLOGY OF AGING

Brain morphometry reproducibility in multi-center 3T MRI studies: A comparison of cross-sectional and longitudinal segmentations

(2013) Jorge Jovicich et al.   NEUROIMAGE

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

(2013) A. Prestia et al.   NEUROLOGY

Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: Implications for early detection of Alzheimer’s disease.

(2013) Yen Ying Lim et al.   NEUROPSYCHOLOGY

White Matter Changes in Patients with Amnestic Mild Cognitive Impairment Detected by Diffusion Tensor Imaging

(2013) Jianghong Liu et al.   PLoS One

Associations between White Matter Hyperintensities and β Amyloid on Integrity of Projection, Association, and Limbic Fiber Tracts Measured with Diffusion Tensor MRI

(2013) Linda L. Chao et al.   PLoS One

The genetics and neuropathology of frontotemporal lobar degeneration

(2012) Anne Sieben et al.   ACTA NEUROPATHOLOGICA

Worldwide Alzheimer’s Disease Neuroimaging Initiative

(2012) Maria C. Carrillo et al.   Alzheimers & Dementia

Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer’s disease

(2012) Milap A. Nowrangi et al.   Alzheimers & Dementia

Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia

(2012) Peder Buchhave   ARCHIVES OF GENERAL PSYCHIATRY

Applicability of the CANTAB-PAL Computerized Memory Test in Identifying Amnestic Mild Cognitive Impairment and Alzheimer’s Disease

(2012) Jenny Junkkila et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Resting state cortical electroencephalographic rhythms are related to gray matter volume in subjects with mild cognitive impairment and Alzheimer's disease

(2012) Claudio Babiloni et al.   HUMAN BRAIN MAPPING

Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion

(2012) Eric Westman et al.   NEUROIMAGE

Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease

(2012) M. Wagner et al.   NEUROLOGY

CSF and Brain Structural Imaging Markers of the Alzheimer's Pathological Cascade

(2012) Xianfeng Yang et al.   PLoS One

Diffusion Tensor Metrics as Biomarkers in Alzheimer's Disease

(2012) Julio Acosta-Cabronero et al.   PLoS One

The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers

(2011) Niklas Mattsson et al.   Alzheimers & Dementia

Association Between In Vivo Fluorine 18–Labeled Flutemetamol Amyloid Positron Emission Tomography Imaging and In Vivo Cerebral Cortical Histopathology

(2011) David A. Wolk   ARCHIVES OF NEUROLOGY

Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease

(2011) Adam S. Fleisher   ARCHIVES OF NEUROLOGY

Changes in cognition

(2011) Marilyn S. Albert   NEUROBIOLOGY OF AGING

Hippocampal dysfunction in patients with mild cognitive impairment: A functional neuroimaging study of a visuospatial paired associates learning task

(2011) Mischa de Rover et al.   NEUROPSYCHOLOGIA

Waveform Analysis of Non-Oscillatory Independent Components in Single-Trial Auditory Event-Related Activity in Healthy Subjects and Alzheimers Disease Patients

(2010) B.W. Jervis et al.   Current Alzheimer Research

When, where, and how the corpus callosum changes in MCI and AD: A multimodal MRI study

(2010) M. Di Paola et al.   NEUROLOGY

Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB

(2010) S. M. Resnick et al.   NEUROLOGY

Amyloid imaging in mild cognitive impairment subtypes

(2009) David A. Wolk et al.   ANNALS OF NEUROLOGY

APOEpredicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging

(2009) John C. Morris et al.   ANNALS OF NEUROLOGY

Differences in Brain Volume, Hippocampal Volume, Cerebrovascular Risk Factors, and Apolipoprotein E4 Among Mild Cognitive Impairment Subtypes

(2009) Jing He et al.   ARCHIVES OF NEUROLOGY

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

(2009) Clifford R. Jack et al.   BRAIN

Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease

(2009) C. Mulder et al.   CLINICAL CHEMISTRY

White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study

(2009) L A van de Pol et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease

(2009) A. Drzezga et al.   NEUROLOGY

Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database

(2008) S. M. Nestor et al.   BRAIN

PET Amyloid Ligand [11C]PIB Uptake and Cerebrospinal Fluid β-Amyloid in Mild Cognitive Impairment

(2008) J. Koivunen et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Diagnostic Usefulness of Cognitive Auditory Event-Related P300 Subcomponents in Patients With Alzheimers Disease?

(2008) Georg Juckel et al.   JOURNAL OF CLINICAL NEUROPHYSIOLOGY

Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years

(2008) Erik Stomrud et al.   NEUROBIOLOGY OF AGING

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment

(2008) A. S. Fleisher et al.   NEUROLOGY